Switching from Twice-Daily Basal Insulin Injections to Once-Daily Insulin Degludec Injection for Basal-Bolus Insulin Regimen in Japanese Patients with Type 1 Diabetes: A Pilot Study

Figure 1

Study design. CGM was performed at baseline and 4 weeks after switching to insulin degludec. At 12 weeks after switching, glycemic control was evaluated by HbA1c, glycosylated albumin, and fasting plasma glucose.